Recent evidence indicates that cyclophosphamide exposure increases the risk of hematologic malignancies in patients with rheumatoid arthritis. In a large administrative database cohort of patients ...

GLP-1 RA use was associated with significantly lower risk of certain cancers compared with metformin use and insulin use.

The following is a summary of “Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists,” ...

Labor Dr. Wisplinghoff will offer GTC's next-generation sequencing-based tests for solid tumor and hematologic neoplasms.

Labor Dr. Wisplinghoff will, with support from GTC, utilize the proven GTC portfolio of tissue and liquid biopsy testing for hematologic neoplasms and solid tumors. Particularly, comprehensive RNA ...

and myeloproliferative neoplasms (MPN) compared with metformin (hazard ratios, 0.61 and 0.67, respectively). No significant difference was seen in the risk for any other hematologic cancer.

The medication shows particular effectiveness in reducing risk for myelodysplastic syndromes and myeloproliferative neoplasms vs ... risk of developing several hematologic cancers, particularly ...